title: Pulmonary and systemic hepatocyte and keratinocyte growth factors in patients with chronic obstructive pulmonary disease.
abstract: BACKGROUND
  The potential role of growth factors in chronic obstructive pulmonary disease (COPD) has begun to be addressed only recently and is still poorly understood. For this study, we investigated potential abnormalities of hepatocyte growth factor (HGF) and keratinocyte growth factor (KGF) in patients with COPD.
  
  
  METHODS
  To this end, we compared the levels of HGF and KGF, measured by enzyme-linked immunosorbent assay (ELISA), in bronchoalveolar lavage (BAL) fluid and in serum in 18 patients with COPD (62 +/- 9 yrs, forced expiratory volume in one second [FEV1] 57 +/- 12% ref, X +/- standard deviation of mean), 18 smokers with normal lung function (58 +/- 8 yrs, FEV1 90 +/- 6% ref) and 8 never smokers (67 +/- 9 yrs, 94 +/- 14% ref).
  
  
  RESULTS
  We found that in BAL, HGF levels were higher in patients with COPD than in the other two groups whereas, in serum, HGF concentration was highest in smokers with normal lung function (p < 0.01). KGF levels were not significantly different between groups, neither in blood nor in BAL (most values were below the detection limit).
  
  
  CONCLUSIONS
  These results highlight a different response of HGF in BAL and serum in smokers with and without COPD that may be relevant for tissue repair in COPD.
authors.affiliation: Servei de Pneumologia, Hospital Universitari Son Dureta, Fundació Caubet-Cimera Illes Balears, Illes Balears, Spain. jsauleda@hsd.es
authors.forename: Jaume
authors.initials: J
authors.lastname: Sauleda
authors.forename: Aina
authors.initials: A
authors.lastname: Noguera
authors.forename: David
authors.initials: D
authors.lastname: Blanquer
authors.forename: Jaume
authors.initials: J
authors.lastname: Pons
authors.forename: Meritxell
authors.initials: M
authors.lastname: López
authors.forename: Cristina
authors.initials: C
authors.lastname: Villena
authors.forename: Alvar G N
authors.initials: AG
authors.lastname: Agustí
mesh_terms: D000280:Administration, Inhalation; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000368:Aged; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry / Q000166:cytology; D004797:Enzyme-Linked Immunosorbent Assay; D051523:Fibroblast Growth Factor 7 / Q000032:analysis* / Q000097:blood; D005541:Forced Expiratory Volume; D017228:Hepatocyte Growth Factor / Q000032:analysis* / Q000097:blood; D006801:Humans; D008168:Lung / Q000737:chemistry*; D008875:Middle Aged; D029424:Pulmonary Disease, Chronic Obstructive / Q000097:blood / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology; D012907:Smoking / Q000097:blood / Q000378:metabolism*
chemical_list: D000305:Adrenal Cortex Hormones; C496453:FGF7 protein, human; C066855:HGF protein, human; D051523:Fibroblast Growth Factor 7; D017228:Hepatocyte Growth Factor